TTP disease course is independent of myeloma treatment and response.
Hofmeister
Craig C
CC
Jin
Ming
M
Cataland
Spero R
SR
Benson
Don M
DM
Wu
Haifeng M
HM
D051722:ADAM Proteins / Q000037:antagonists & inhibitors / Q000172:deficiency; D000071120:ADAMTS13 Protein; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy
D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human